Skip to main content
. 2003 Feb;55(2):158–165. doi: 10.1046/j.1365-2125.2003.01754.x

Table 1.

Frequencies of the slow acetylator genotypes and phenotypes in HIV-positive patients with and without hypersensitivity to SMX, and in healthy volunteers.

HIV-positive patients
NAT2 genotype/ phenotype SMX- hypersensitive (n = 32) SMX- nonhypersensitive (n = 8) Healthy volunteers (n = 26)
Slow genotype 20 (63%) 3 (38%) 18 (69%)
Slow phenotype 17 (53%) 3 (38%) 17 (65%)

NAT2, N-acetyl transferase type 2; SMX, sulphamethoxazole.